Nuclear magnetic resonance and molecular modeling study on mycophenolic acid: Implications for binding to inosine monophosphate dehydrogenase

Journal of Medicinal Chemistry

Volumn 39, Issue 6, 1996, Pages 1236-1242

  Makara, Gergely M ^a   Keserû, György M ^c   Kajtár Peredy, Mária ^b   Anderson, Wayne K ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b CTRL RES INSTITUTE FOR CHEMISTRY   (Hungary)

^c BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE INHIBITOR; MYCOPHENOLIC ACID; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG;

DRUG BINDING; DRUG STRUCTURE; ENZYME BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; REVIEW;

ENZYME INHIBITORS; IMP DEHYDROGENASE; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MYCOPHENOLIC ACID; NAD;

EID: 0029922331     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950600m     Document Type: Review

References (52)

1. (a) Stet, E. H.; De Abreu, R. A.; Janssen, Y. P.; Bokkerink, J. P.; Trijbels, F. J. A Biochemical Basis for Synergism of 6-Mercaptopurine and Mycophenolic Acid in Molt F4, a Human Malignant T-Lymphoblastic Cell Line. Biochim. Biophys. Acta 1993, 1180, 277-282 .
2. (b) Stet, E. H.; Deabreu, R. A.; Bokkerink, J. P. M.; Lambody, L. H. J.; Vogelsmentink, T. M.; Trijbels, F. J. M. Inhibition of IMP Dehydrogenase by Mycophenolic Acid in Molt F4 Human Malignant Lymphoblasts. Ann. Clin. Biochem. 1994, 31, 174-180.
3. (c) Wilson, B. S.; Deanin, G. G.; Standefer, J. C.; Vanderjagt, D.; Oliver, J. M. Depletion of Guanine Nucleotides with Mycophenolic Acid Suppresses Ige Receptor-Mediated Degranulation in Rat Basophilic Leukemia Cells. J. Immunol. 1989, 143, 259-265.
4. (d) Mitsui, A.; Matsuno, T.; Ogawa, H.; Shiio, T.; Yugari, Y.; Tamura, G. Antitumor Activity of a New Compound, Ethyl O-[N-(P-Carboxyphenyl)-carbamoyl]-mycophenolate, Against Various Experimental Tumors Upon Oral Administration. Gann 1981, 72, 66-71.
5. (e) Bates, T. A Preliminary Clinical Study of the Use of Mycophenolic Acid as a Radiosensitizer. Eur. J. Cancer 1977, 13, 475-477.
6. (f) Suzuki, S.; Mori, T. Carbamoyl Mycophenlic Acid Ethylester, an Oral Antitumor Agent. J. Antibiot. 1976, 29, 286-291.
7. (g) Suzuki, S.; Takaku, S.; Mori, T. Antitumor Activity of Derivatives of Mycophenolic Acid. J. Antibiot. 1976, 29, 275-285.
8. (h) Connolly, J. G.; Halsall, G. M. Use of Mycophenolic Acid in Superficial Bladder Cancer. Urology 1975, 5, 131-132.
9. (i) Knudtzon, S., Nissen, N. I. Clinical Trial with Mycophenolic Acid (NSC-129185), a New Antitumor Agent. Cancer Chemother. Rep. Part 1 1972, 56, 221-227.
10. (J) Sweeney, M. J.; Gerzon, K.; Harris, P. N.; Holmes, R. E.; Poore, G. A.; Williams, R. H. Experimental Antitumor Activity and Preclinical Toxicology of Mycophenolic Acid. Cancer Res. 1972, 32, 1795-1802.
11. (k) Sweeney, M. J.; Hoffman, D. H.; Poore, G. A. Possible In Situ Activation of Mycophenolic Acid by Beta-Glucuronidase. Cancer Res. 1971, 32, 477-478.
12. (l) Suzuki, S.; Kimura, T., Ando, K.; Sawada, M.; Tamura, G. Antitumor Activity of Mycophenolic Acid. J. Antibiot. 1969, 22, 297-302.
13. (a) Berman, J. D.; Webster, H. K. In Vitro Effects of Mycophenolic Acid and Allopurinol Against Leishmania Tropica in Human Macrophages. Antimicrob. Agents Chemother. 1982, 21, 877-891.
14. (b) Verham, R.; Meek, T. D.; Hedstrom, L.; Wang, C. C. Purification, Characterization, and Kinetic Analysis of Inosine 5′-Monophosphate Dehydrogenase of Tritrichomonas Foetus. Mol. Biochem. Parasitai. 1987, 24, 1-12.
15. (c) Noto, T.; Sawada, M.; Ando, K.; Koyama, K. Some Biological Properties of Mycophenolic Acid. J. Antibiot. 1969, 22, 165-169.
16. (a) Alfieri, C.; Allison, A. C.; Kieff, E. Effect of Mycophenolic Acid on Epstein-Barr Virus Infection of Human B-Lymphocytes. Antimicrob. Agents Chemother. 1994, 38, 126-129.
17. (b) Cline, J. C.; Nelson, J. D.; Gerzon, K.; Williams, R. H.; DeLong, D. C. In Vitro Antiviral Activity of Mycophenolic Acid and Its Reversal by Guanine-Type Compounds. Appl. Microbiol. 1969, 18, 14-20.
18. (c) Planterose, D. N. Antiviral and Cytotoxic Effects of Mycophenolic Acid. J. Gen. Virol. 1969, 4, 629-630.
19. (d) Williams, R. H.; Lively, D. H.; DeLong, D. C.; Cline, J. C.; Sweeney, M. J. Mycophenolic Acid: Antiviral and Antitumor Properties. J. Antibiot. 1968, 27, 463-464.
20. (a) Gomez, E. C.; Menendez, L.; Frost, P. Efficacy of Mycophenolic Acid for the Treatment of Psoriasis. J. Am. Acad. Dermatol. 1979, 1, 531-537.
21. (b) Sweeney, M. J. Mycophenolic Acid and Its Mechanism of Action in Cancer and Psoriasis. J. Antibiot. 1977, 30S, 85-92.
22. (c) Marinari, R. Fleischmajer, R.; Schragger, A. H.; Rosenthal, A. L. Mycophenolic Acid in the Treatment of Psoriasis: Long-Term Administration. Arch. Dermatol. 1977, 113, 930-932.
23. (d) Lynch, W. S.; Roenigk, H. H., Jr. Mycophenolic Acid for Psoriasis. Arch. Dermatol. 1977, 113, 1203-1208.
24. (a) Yamada, Y.; Natsumeda, Y.; Weber, G. Action of the Active Metabolites of Tiazofurin and Ribavirin on Purified IMP Dehydrogenase. Biochemistry 1988, 27, 2193-2196.
25. (b) Lee, H.-J.; Pawlak, K.; Nguyen, B. T., Robins, R. K.; Sadee, W. Biochemical Differences Among Four Inosinate Dehydrogenase Inhibitors, Mycophenolic Acid, Ribavirin, Tiazofurin, and Selenazofurin, Studied in Mouse Lymphoma Cell Culture. Cancer Res. 1985, 45, 5512-5520.
26. (c) Gebeyehu, G.; Marquez, V. E.; Van Cott, A.; Cooney, D. A.; Kelley, J. A.; Jayaram, H. N.; Ahluwalia, G. S.; Dion, R. L.; Wilson, Y. A.; Johns, D. G. Ribavirin, Tiazofurin, and Selenazofurin: Mononucleotides and Nicotinamide Adenine Dinucleotide Analogues. Synthesis, Structure, and Interactions with IMP Dehydrogenase. J. Med. Chem. 1985, 28, 99-105.
27. Hedstrom, L.; Wang, C. C. Mycophenolic Acid and Thiazole Adenine Dinucleotide Inhibition of Tritrichomonas foetus Inosine Monophosphate Dehydrogenase: Implications on Enzyme Binding. Biochemistry 1990, 29, 849-854.
28. (a) Goldstein, B. M.; Bell, J. E.; Marquez, V. E. Dehydrogenase Binding by Tiazofurin Anabolites. J. Med. Chem. 1990, 33, 1123-1127.
29. (b) Li, H.; Hallows, W. H.; Punzi, J. S.; Marquez, V. E.; Carell, H. L.; Pankiewicz, K. W.; Watanabe, K. A.; Goldstein, B. M. Cristallographic Studies of Two Alcohol Dehydrogenase-Bound Analogues of Thiazole-4-carboxamide Adenine Dinucleotide (TAD), the Active Anabolite of the Antitumor Agent Tiazofurin. Biochemistry 1994, 33, 23-32.
30. SYBYL 6.1, Tripos Associates Inc.; MOPAC 6.0 (QCPE #455).
31. SYBYL's Multifit command.
32. + and NADH Analogs: Protonated Nicotinamide and 1,4-Dihydronicotinamide. J. Org. Chem. 1993, 58, 2043-2045.
33. Protein Data Bank, Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973.
34. (a) Oppenheimer, N. J.; Marschner, T. M.; Malver, O.; Kam, B. L. Stereochemical Aspects of Coenzyme-Dehydrogenase Interactions. In Mechanism of Enzymatic Reactions: STEREOCHEMISTRY; Frey, P. A., Ed.; Elsevier Science Publishing Co.: New York, 1986; pp 15-28.
35. (b) Benner, S. A.; Nambiar, K. P. Functional Explanations for Stereoselectivity in Dehydrogenases. In Mechanism of Enzymatic Reactions: STEREOCHEMISTRY; Frey, P. A., Ed.; Elsevier Science Publishing Co.: New York, 1986; pp 29-43.
36. Jayaram, H. N.; Johns, D. G. Metabolic and Mechanistic Studies with Tiazofurin (2-b-D-ribofuranosylthiazole-4-carboxamide). In Developments in Cancer Chemotherapy; Glazer, R. I., Ed.; CRC Press; Boca Raton, FL, 1984; pp 115-130.
37. Burling, F. T.; Goldstern, B. M. Computational Studies of Nonbonded Sulfur-Oxygen and Selenium-Oxygen Interactions in the Thiazole and Selenazole Nucleosides. J. Am. Chem. Soc. 1992, 114, 2313-2320.
38. Brookhaven data bank file Igrb.full.
39. Eklund, H.; Samama, J.-P.; Jones, T. A. Crystallographic Investigation of Nicotinamide Adenine Dinueleotide Binding to Horse Liver Alcohol Dehydrogenase. Biochemistry 1984, 23, 5982-5996.
40. Cox, S. R.; Williams, D. E. Representation of the Molecular Electrostatic Potential by a Net Atomic Charge Model. J. Comput. Chem. 1981, 2, 304-323.
41. Walters, D. E.; Hinds, R. M. Genetically Evolved Receptor Models: A Computational Approach to Construction of Receptor Models. J. Med. Chem. 1994, 37, 2527-2536.
42. 1/2.
43. Anderson, W. K.; Boehm, T. L.; Makara, G.; Swann, R. T. Synthesis and Modeling Studies with Monocyclic Analogues of Mycophenolic Acid. J. Med. Chem. 1996, 39, 46-55.
44. Jones, D. F.; Mills, S. D. Preparation and Antitumor Properties of Analogs and Derivatives of Mycophenolic Acid. J Med. Chem. 1971, 14, 305-311.
45. Cram, D. J. The Design of Molecular Hosts, Guests, and Their Complexes. Science 1988, 240, 760-767.
46. Goldstein, B. M.; Li, H.; Hallows, W. H.; Langs, D. A; Franchetti, P.; Cappellacci, L.; Grifantini, M. C-glycosyl Bond Conformation of Oxazofurin-Crystallographic and Computational Studies of the Oxazole Analogue of Tiaofurin. J. Med. Chem. 1994, 37, 1684-1688.
47. Hupe, D. J.; Azzolina, B. A; Behrens, N. D. IMP Dehydrogenase from the Intracellular Parasitic Protozoan Eimeria Tenella and Its Inhibition by Mycophenolic Acid. J. Biol. Chem. 1986, 261, 8363-8369.
48. Jackson, R. C.; Weber, G.; Morris, H. P. IMP Dehydrogenase, an Enzyme Linked with Proliferation and Malignancy. Nature 1975, 256, 331-333.
49. Baker, P. J.; Britton, K. L.; Engel, P. C.; Farrants, G. W.; Lilley, K. S.; Rice, D. W.; Stillman, T. J. Subunit Assembly and Active Site Location in the Structure of Glutamate Dehydrogenase. Proteins 1992, 12, 75-86.
50. Harrison, W.; Shearer, M. M.; Trotter, J. Crystal Structure of Mycophenolic Acid. J. Chem. Soc., Perkin Trans. II 1972, 1542-1544.
51. Sanders, J. K. M.; Mersh, J. D. Nuclear Magnetic Double Resonance: the Use of Difference Spectroscopy. Prog. Nucl. Magn. Reson. Spectros. 1983, 15, 353-400.
52. Kinns, M.; Sanders, J. K. M. Improved Frequency Selectivity in Nuclear Overhauser Effect. J. Magn. Reson. 1984, 56, 518-520.